Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Quick approval pathways challenge teams to balance compliance with the need for speed. 

Pre-Clinical: Laying the Right Foundation

Alberto Santagostino is senior vice-president and head of cell and gene technologies at Lonza Pharma and Biotech. 

Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost. 

Using the ‘Cubic Effect’ to Drive Cell and Gene Therapy Commercialization

Catalent builds on its investment in cell and gene therapy development and manufacturing with the acquisition of MaSTherCell Global.

Catalent to Acquire MaSTherCell Global for $315 Million

In replacing the retiring Paul Hegwood, Ricci Whitlow will oversee global clinical trial operations.

Whitlow to Lead Catalent’s Clinical Supply Services Business

Tim Roach is senior director of plant engineering at Recro Gainesville.

Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.

Best Practices for Design and Operation of Multiproduct Manufacturing Facilities

Shreekant Karmarkar, PhD, is president, DAT Pharma Consulting, Inc., skarmarkar@DATPharmaConsulting.com, 1-224-383-4493

How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.

Building Strategic Relationships with CROs

Kai Vogt is senior vice-president Corporate Development, Legal and Compliance, Information Technology at Vetter Pharma. 

CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects. 

Digitalization: A CDMO’s Perspective

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

As cell and gene therapies become more prominent, industry is seeking the expertise and capabilities of outsourcing partners to ensure success.

Sourcing Success in Cell and Gene Therapy Development

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.

More Capacity and Technology Translate to More Options

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.